Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
+0.00%
trims when stocks drop
when a holding falls −10%+
Middle response
+0.00%
baseline attrition
Rally response
+0.00%
adds into rallies
when a holding rises +10%+
Top positions · 3
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| BCAXBicara Therapeutics Inc. | $63M | 56.4% | +52.6% | 1.5 yr |
| CBLLCeriBell, Inc. | $40M | 36.2% | -4.6% | 1.5 yr |
| CTNMContineum Therapeutics, | $8M | 7.5% | +87.1% | 1.5 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology63.8%+9.6pp$71M
Medical - Devices36.2%-9.6pp$40M
Country
US100.0%+0.0pp
Top 5: 100.0% · Top 10: 100.0% · Top 25: 100.0%
Losers
| Ticker | Prev $ | PnL | YoY % |
|---|---|---|---|
| CBLL | $42M | -0.00B | -4.6% |
Top buys this quarter · 0
No buys this quarter
Top sells this quarter · 0
No sells this quarter
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $112M | 3 | +26.88% | +17.59% | +9.29% | -0.00B |
| 2025-12-31 | $109M | 3 | -10.39% | +17.72% | -28.11% | -0.00B |
| 2025-09-30 | $83M | 3 | +13.10% | +8.12% | +4.98% | -0.00B |
| 2025-06-30 | $73M | 3 | -16.83% | +10.78% | -27.61% | -0.00B |
| 2025-03-31 | $93M | 4 | -27.56% | -4.27% | -23.29% | -0.02B |
| 2024-12-31 | $152M | 4 | — | — | — | — |